StockWatch
·
Pharmaceuticals
AGM/EGM12 May 2026, 06:01 pm

Neuland Labs: AGM on Aug 4, 2026; ₹34 Dividend Declared

AI Summary

Neuland Laboratories Ltd has announced its 42nd Annual General Meeting (AGM) scheduled for August 4, 2026. The Board approved audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹34 (340%) per equity share. Dr. Mauricio Futran was appointed as an Additional Director (Non-Executive Non-Independent), subject to shareholder approval. The company also approved a capacity enhancement at Unit 1 with an investment of ₹143.4 crores.

Key Highlights

  • 42nd AGM to be held on August 4, 2026; record date fixed as July 24, 2026.
  • Final dividend of ₹34 per share (340%) recommended for FY26.
  • Dr. Mauricio Futran appointed as Additional Director (Non-Executive Non-Independent).
  • Capacity expansion of 120.5 KL at Unit 1 approved with ₹143.4 Cr investment.
  • Audited financial results for FY26 approved with unmodified opinion from auditors.